SCHEMBL30314643

SCHEMBL30314643

CCCCOC(=O)N[C@@H](CC)C(=O)N(C)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
MCL1 Q07820 1/20 0.40
EPHX1 P07099 1/20 0.39
ACHE P22303 7/20 0.38
CASP1 P29466 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
JAK3 P52333 1/20 0.35
BTK Q06187 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30281320 0.90 SMN1; SMN2 (0.39) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL6828291 0.89 CTSL (0.40) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL12164702 0.87 NPC1 (0.37) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL12213979 0.84 SMN1; SMN2 (0.40) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL13970298 0.81 CTSK (0.51) ALDH1A1
SCHEMBL7293004 0.81 CTSK (0.51) ALDH1A1
SCHEMBL1696818 0.81 CA1 (0.46) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL20683487 0.81 CA1 (0.46) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL480292 0.78 EPHX1 (0.46) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL284168 0.78 EPHX1 (0.46) SMN1; SMN2NPC1RAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023057882-A1 COMBINATIONS OF AZALACTAM COMPOUNDS WITH A PD-1 AXIS BINDING ANTAGONIST FOR THE TREATMENT OF CANCER PFIZER INC. (US) 2023-04-13 WO disclosed